![PeerVoice Endocrinology & Metabolic Disorders Audio artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/af/9d/9c/af9d9cc8-ce19-1840-fb9a-19da27c33776/mza_2112321423516383064.jpg/100x100bb.jpg)
PeerVoice Endocrinology & Metabolic Disorders Audio
83 episodes - English - Latest episode: 2 months ago - ★★★ - 6 ratingsPeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes
August 06, 2021 23:00 - 44 minutesPersonalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
July 16, 2021 23:00 - 8 minutesEvaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021
June 23, 2021 23:00 - 8 minutesEvaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021
Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs
June 17, 2021 23:00 - 21 minutesStep-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs
Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin
June 10, 2021 23:00 - 32 minutesWhy Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin
Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?
May 03, 2021 23:00 - 39 minutes"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"
"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"
May 03, 2021 23:00 - 39 minutes"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"
Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?
April 30, 2021 23:00 - 19 minutesCould PSMA Be the ‘Bulls-Eye’ Target in mCRPC?
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
February 03, 2021 23:00 - 44 minutesStroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
SGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020
January 08, 2021 23:00 - 37 minutesSGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights of Kidney Week 2020
January 06, 2021 23:00 - 10 minutesEvaluating the Evidence for SGLT2 Inhibition in CKD: Highlights of Kidney Week 2020
Novel Strategies for Chronic Kidney Disease: New Data, New Paradigm?
January 06, 2021 23:00 - 21 minutesNovel Strategies for Chronic Kidney Disease: New Data, New Paradigm?
Modern Management of Chronic Kidney Disease: A Look to the Future
November 11, 2020 23:00 - 15 minutesModern Management of Chronic Kidney Disease: A Look to the Future
Breaking the Cycle of Severe Hypoglycemia in Diabetes: Educating Clinicians and Patients Alike
November 04, 2020 23:00 - 20 minutesBreaking the Cycle of Severe Hypoglycemia in Diabetes: Educating Clinicians and Patients Alike
New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors
October 21, 2020 23:00 - 12 minutesNew Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors
Evaluating the Evidence for SGLT2 Inhibition in CKD
October 19, 2020 23:00 - 19 minutesEvaluating the Evidence for SGLT2 Inhibition in CKD
Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?
October 15, 2020 23:00 - 36 minutesHalting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?
Managing Youth-Onset Type 2 Diabetes: What Paediatricians Need to Know
July 22, 2020 23:00 - 19 minutesManaging Youth-Onset Type 2 Diabetes: What Paediatricians Need to Know
Hiding in Plain Sight: Identifying Patients at Risk for NASH
June 19, 2020 23:00 - 24 minutesHiding in Plain Sight: Identifying Patients at Risk for NASH
Managing Complicated Cases in Type 2 Diabetes
June 08, 2020 23:00 - 14 minutesManaging Complicated Cases in Type 2 Diabetes
Heart Matters in T2DM: The Experts Weigh In
April 02, 2020 23:00 - 25 minutesHeart Matters in T2DM: The Experts Weigh In
Imagining a World Without Hepatitis C Virus: A Call to Action
April 02, 2020 23:00 - 10 minutesImagining a World Without Hepatitis C Virus: A Call to Action
Managing Lipid-Related Cardiovascular Risk: What We Know Now
January 06, 2020 23:00 - 19 minutesManaging Lipid-Related Cardiovascular Risk: What We Know Now
Setting a Path for Success in Type 2 Diabetes: What We Know Now
November 08, 2019 23:00 - 1 hourSetting a Path for Success in Type 2 Diabetes: What We Know Now
Warming Up to Novel Approaches for Primary Cold Agglutinin Disease: Strategies for Correct Diagnosis and Optimal Treatment
November 04, 2019 23:00 - 16 minutesWarming Up to Novel Approaches for Primary Cold Agglutinin Disease: Strategies for Correct Diagnosis and Optimal Treatment
Evaluating the Latest Data in Ulcerative Colitis
November 01, 2019 23:00 - 17 minutesEvaluating the Latest Data in Ulcerative Colitis
PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
October 30, 2019 23:00 - 9 minutesPARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
Getting at the Heart of Comprehensive Disease Control in Type 2 Diabetes: What’s New?
October 23, 2019 23:00 - 1 hourGetting at the Heart of Comprehensive Disease Control in Type 2 Diabetes: What’s New?
A Closer Look at Safety of Glucose-Lowering Therapy
February 27, 2019 23:00 - 18 minutesA Closer Look at Safety of Glucose-Lowering Therapy
Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety
November 06, 2018 23:00 - 1 hourImproving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety
Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
October 17, 2018 23:00 - 1 hourTicking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
Considering the Possibility of Psoriatic Arthritis in Patients With Psoriasis
April 25, 2018 23:00 - 16 minutesConsidering the Possibility of Psoriatic Arthritis in Patients With Psoriasis
Cardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know
April 20, 2018 23:00 - 20 minutesCardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know